Today: 22 January 2026
Subscribe
Browse Category

Pharmaceuticals News 11 January 2026 - 12 January 2026

Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

New York, Jan 12, 2026, 10:13 ET — Regular session Teva Pharmaceutical Industries’ U.S.-listed shares jumped roughly 4% to $33.29 in Monday morning trading. The boost came after the drugmaker unveiled new funding for an experimental vitiligo treatment and offered a glimpse of its year-end outlook. This move is crucial as Teva aims to prove to investors that its growth…
12 January 2026
····
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

New York, January 12, 2026, 05:15 EST — Premarket NovaBay Pharmaceuticals, Inc. shares slipped roughly 10% in early Monday trading, falling to $17.21 after finishing Friday at $19.16. This dip comes after a notable surge in the lightly traded stock on the NYSE American. Stockanalysis Friday’s surge was extreme, even for a microcap. Shares closed up 102.5%, swinging between $9.69…
12 January 2026
····
GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

London, January 12, 2026, 08:41 GMT — Regular session Shares of GSK plc edged down 0.03% to 1,885.5 pence early Monday in London, after fluctuating between 1,870.5 and 1,885.5 pence during the session. The annual J.P. Morgan Healthcare Conference takes place January 12–15 in San Francisco. According to the agenda, GSK is scheduled for a 7:30 a.m. Pacific slot on…
12 January 2026
····
Novo Nordisk stock: Amazon starts selling Wegovy pill, putting next week in focus

Novo Nordisk stock: Amazon starts selling Wegovy pill, putting next week in focus

Copenhagen, January 11, 2026, 23:22 CET — Market closed Novo Nordisk (NOVOb.CO) shares climbed 3% to 381.45 Danish crowns on Friday after Amazon Pharmacy announced it will offer the drugmaker’s Wegovy weight-loss pill through insurance coverage as well as a cash-pay option. The U.S.-listed ADRs (NVO) closed 2.6% higher at $58.81. (Reuters) Novo’s new distribution channel is crucial as the…
11 January 2026
····
Novartis stock on watch as Florida radioligand plant plan tees up JPM conference week

Novartis stock on watch as Florida radioligand plant plan tees up JPM conference week

New York, January 11, 2026, 14:15 EST — Market closed. Novartis AG’s U.S.-listed shares (NVS) closed Friday mostly flat. Still, the stock starts the new week with a notable development: the company announced a new U.S. manufacturing facility for its radioligand cancer therapies. (Novartis) The timing matters because radioligand therapy demands tight logistics — every dose is tailored to a…
11 January 2026
···
Merck (MRK) stock week ahead: $30 billion Revolution talks and JPMorgan catalysts to watch

Merck (MRK) stock week ahead: $30 billion Revolution talks and JPMorgan catalysts to watch

New York, January 11, 2026, 14:03 EST — Market closed. Merck & Co., Inc. shares closed down 0.4% on Friday at $110.53, and traders head into Monday with takeover chatter back in the tape. The Wall Street Journal reported Merck is in talks to buy Revolution Medicines in a deal valued around $28 billion to $32 billion. (The Wall Street…
11 January 2026
····
AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

London, Jan 11, 2026, 16:43 GMT — Market closed. AstraZeneca shares head into Monday’s session under pressure after Nasdaq announced Walmart will take the drugmaker’s spot in the Nasdaq-100 starting Jan. 20. (Reuters) This is significant today since index trackers often translate a calendar shift into actual trades. Funds following the Nasdaq-100 usually tweak their holdings near the effective date,…
11 January 2026
····
Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus

Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus

ZURICH, Jan 11, 2026, 17:40 CET — The market has closed. Roche Holding shares rose 0.4% on Friday following news that China’s MediLink Therapeutics inked a licensing deal with the Swiss pharma giant for an experimental cancer drug. The stock closed at 340.80 Swiss francs on the SIX Swiss Exchange. (MarketWatch) The deal underscores how big pharma continues to invest…
11 January 2026
····
Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

New York, Jan 11, 2026, 10:45 EST — Market closed. Shares of Johnson & Johnson (JNJ.N) dipped 0.7% on Friday to $204.39 following the company’s announcement of a deal with the Trump administration to lower U.S. drug prices. In return, J&J secured exemptions from certain U.S. tariffs. The company said it will offer medicines at discounted rates via TrumpRx.gov and…
11 January 2026
····
Eli Lilly stock (LLY) slips into JPM Week as Amazon adds rival Wegovy pill — what to watch next

Eli Lilly stock (LLY) slips into JPM Week as Amazon adds rival Wegovy pill — what to watch next

New York, Jan 11, 2026, 10:13 EST — Market closed Eli Lilly and Company shares dropped 1.99% on Friday, closing at $1,063.56. The stock heads into Monday’s session under pressure after a volatile week for major pharmaceutical firms. Investors are closely eyeing signs of a pricing battle in the obesity-drug sector after Amazon Pharmacy announced it now stocks Novo Nordisk’s…
11 January 2026
····
OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

New York, Jan 11, 2026, 08:51 (EST) — Market closed. Olema Pharmaceuticals Inc shares closed up 9.8% on Friday at $28.08, with about 2.5 million shares changing hands, as investors headed into a catalyst-heavy week for the cancer drug developer. (The Wall Street Journal) U.S. markets reopen on Monday, and Olema is the kind of stock that can gap on…
11 January 2026
····
NovaBay Pharmaceuticals stock jumps 102% — what to watch for NBY before Monday

NovaBay Pharmaceuticals stock jumps 102% — what to watch for NBY before Monday

New York, January 11, 2026, 07:38 EST — The market has closed. Shares of NovaBay Pharmaceuticals, Inc (NBY) soared Friday, closing up 102.5% at $19.16. The NYSE American stock will remain in focus when U.S. markets reopen Monday. (Daily Times Leader) Friday’s session ended a wild ride for the microcap, with shares bouncing between $9.69 and $19.95. Trading volume surged…
11 January 2026
····
1 … 6 7 8 9 10 … 45

Stock Market Today

  • RBB Shares Surge 5.1% Amid Tariff-Relief Rally, Earnings Expectations in Focus
    January 22, 2026, 9:48 AM EST. RBB shares rallied 5.1% to $22.33, reversing recent losses on high trading volume following tariff relief news linked to Greenland. The bank holding company's upcoming quarterly earnings report projects 96% year-over-year EPS growth to $0.49 and revenues up 14.7% to $32.94 million. However, consensus earnings estimates have remained flat over the past month, which may limit sustained price momentum absent positive revisions. RBB holds a Zacks Rank #3 (Hold) amid sector peers like Bank of Marin, which gained 5% with an improving earnings outlook and a Rank #1 (Strong Buy). Investors should monitor earnings estimate trends closely to assess whether RBB's recent jump can extend further.
Go toTop